Evidence map›Paper›PMID 24911871›Full record

ArticlePloS one2014

Cell-mediated degradation regulates human mesenchymal stem cell chondrogenesis and hypertrophy in MMP-sensitive hyaluronic acid hydrogels.

Qian Feng, Meiling Zhu, Kongchang Wei, Liming Bian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qian FengDivision of Biomedical Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China; Department of Mechanical and Automation Engineering and the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China.
Meiling ZhuDivision of Biomedical Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China; Department of Mechanical and Automation Engineering and the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China.
Kongchang WeiDivision of Biomedical Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China; Department of Mechanical and Automation Engineering and the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China.
Liming BianDivision of Biomedical Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China; Department of Mechanical and Automation Engineering and the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong, Hong Kong, the People's Republic of China; The Chinese University of Hong Kong Shenzhen Research Institute, the People's Republic of China.
Chinese University of Hong Kong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photocrosslinked methacrylated hyaluronic acid (MeHA) hydrogels support chondrogenesis of encapsulated human mesenchymal stem cells (hMSCs). However, the covalent crosslinks formed via chain polymerization in these hydrogels are hydrolytically non-degradable and restrict cartilage matrix spatial distribution and cell spreading. Meanwhile, cells are known to remodel their surrounding extracellular matrix (ECM) by secreting catabolic enzymes, such as MMPs. Hydrogels that are created with bifunctional crosslinkers containing MMP degradable peptide sequences have been shown to influence hMSC differentiations. However, crosslinks formed in the MMP-degradable hydrogels of these previous studies are also prone to hydrolysis, thereby confounding the effect of MMP-mediated degradation. The objective of this study is to develop a MMP-sensitive but hydrolytically stable hydrogel scaffold and investigate the effect of MMP-mediated hydrogel degradation on the chondrogenesis of the encapsulated hMSCs. Hyaluronic acid macromers were modified with maleimide groups and crosslinked with MMP-cleavable peptides or control crosslinkers containing dual thiol groups. The chondrogenesis of the hMSCs encapsulated in the hydrolytically stable MMP-sensitive HA hydrogels were compared with that of the MMP-insensitive HA hydrogels. It was found that hMSCs encapsulated in the MMP-sensitive hydrogels switched to a more spreaded morphology while cells in the MMP-insensitive hydrogels remained in round shape. Furthermore, hMSCs in the MMP-sensitive hydrogels expressed higher level of chondrogenic marker genes but lower level of hypertrophic genes compared to cells in the MMP-insensitive hydrogels. As a result, more cartilage specific matrix molecules but less calcification was observed in the MMP-degradable hydrogels than in the MMP-insensitive hydrogels. Findings from this study demonstrate that cell-mediated scaffold degradation regulates the chondrogenesis and hypertrophy of hMSCs encapsulated in HA hydrogels.

Indexed as

Cell Culture TechniquesChondrogenesisBiomarkersCalcification, PhysiologicCells, CulturedCell SurvivalExtracellular MatrixGene Expression ProfilingHumansHyaluronic AcidHydrogel, Polyethylene Glycol DimethacrylateMatrix MetalloproteinasesMesenchymal Stem CellsBiomarkersHyaluronic AcidHydrogel, Polyethylene Glycol DimethacrylateMatrix Metalloproteinases

Identifiers

PMID24911871
PMCPMC4049825
OpenAlexW2006595175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.